Ingevity (NGVT) Tops Q2 EPS by 4c, misses on revenue, provides guidance

Ingevity (NYSE: NGVT) reported Q2 EPS of $1.41, $0.04 better than the analyst estimate of $1.37. Revenue for the quarter came in at $481.8 million versus the consensus estimate of $486.43 million.

GUIDANCE:

Ingevity sees FY2023 revenue of $1.6-1.7 billion, and adjusted EBITDA between $390 million and $420 million.

For earnings history and earnings-related data on Ingevity (NGVT) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Evercore ISI Starts Credo Tech (CRDO) at Outperform
• AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion